References
- Evens AM, Winter JN, Gordon LI, et al. Non-hodgkin lymphoma. Cancer Network 2015 [Last accessed 3 Nov 2017] http://www.cancernetwork.com/cancer-management/non-hodgkin-lymphoma
- Institute for Health Metrics (IHME). GBD Results Tool. Seattle (WA): IHME, University of Washington, 2015
- Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006;107:265-76
- Maurer MJ, Ghesquieres H, Jais JP, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol 2014;32:1066-73
- Heutte N, Haioun C, Feugier P, et al. Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant. Leuk Lymphoma 2011;52:1239-48
- Thompson CA, Maurer MJ, Allmer C, et al. QOL at 3 years after diagnosis in aggressive lymphoma survivors. J Clin Oncol 2015;33(15 suppl):9586
- Arden-Close E, Pacey A, Eiser C. Health related quality of life (HRQoL) in survivors of lymphoma: a systematic review and methodological critique. Leuk Lymphoma 2010;51:628-40
- Bellizzi KM, Miller MF, Arora NK, et al. Positive and negative life changes experienced by survivors of non-Hodgkin’s lymphoma. Ann Behav Med 2007;34:188-99
- Bellizzi KM, Rowland JH, Arora NK, et al. Physical activity and quality of life in adult survivors of non-Hodgkin’s lymphoma. J Clin Oncol 2009;27:960-6
- Vallance JK, Courneya KS, Jones LW, et al. Differences in quality of life between non‐Hodgkin’s lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology 2005;14:979-91
- Mols F, Aaronson NK, Vingerhoets AJ, et al. Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study. Cancer 2007;109:1659-67
- National Institute for Health and Care Excellence (NICE). Chapter 4 Developing review questions and planning the evidence review. 2014, updated 2017. Available at https://www.nice.org.uk/process/pmg20/chapter/developing-review-questions-and-planning-the-evidence-review [Last accessed 28 July 2017]
- Ruan J, Martin P, Shah B, et al. Lenalidomide plus rituximab as initial treatment for mantle-cell lymphoma. N Engl J Med 2015;373:1835-44
- Oerlemans S, Issa DE, van den Broek EC, et al. Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry. Ann Hematol 2014;93:1705-15
- Oerlemans S, Mols F, Nijziel MR, et al. The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv 2014;8:555-64
- Hudson KE, Benecha HK, Houck KL, et al. Fatigue in long-term non-Hodgkin lymphoma survivors. J Clin Oncol 2015;33(suppl):abstract e20628
- Holland RA, Bird BR, Cahill M, et al. Assessing the quality of life of non-Hodgkin lymphoma survivors: a population-based study. J Clin Oncol 2016;34(3 suppl):227
- Glaser AW, Fraser LK, Corner J, et al. Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey. BMJ Open 2013;3:e002317
- Jefford M, Ward AC, Lisy K, et al. Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. Support Care Cancer 201710:3171-3179
- Jensen RE, Arora NK, Bellizzi KM, et al. Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma. Cancer 2013;119:672-80
- Kim SH, Kim IR, Kim SH, et al. Health-related quality of life in Korean lymphoma survivors compared with the general population. Ann Hematol 2014;93:1531-40
- Beaven AW, Samsa G, Zimmerman S, et al. Quality of life is similar between long-term survivors of indolent and aggressive non-Hodgkin lymphoma. Cancer Invest 2016;34:279-85
- Smith SK, Crespi CM, Petersen L, et al. The impact of cancer and quality of life for post-treatment non-Hodgkin lymphoma survivors. Psychooncology 2010;19:1259-67
- Parker PA, Banerjee SC, Matasar MJ, et al. Protocol for a cluster randomised trial of a communication skills intervention for physicians to facilitate survivorship transition in patients with lymphoma. BMJ Open 2016;6:e011581